ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI
Entero Therapeutics (NASDAQ:ENTO) has announced a transformative acquisition of GRID AI Corp, positioning itself in the rapidly growing AI energy-infrastructure market. GRID AI's platform utilizes AI and machine learning to manage distributed energy resources and balance power supply and demand in real-time.
The deal structure gives GRID AI shareholders 82.5% ownership of ENTO's fully diluted common stock, while existing ENTO shareholders retain 17.5%. GRID AI's technology addresses the surging power demands from AI data centers, with Goldman Sachs projecting global data-center power demand to increase ~50% by 2027 and up to 165% by 2030 versus 2023 levels.
The acquisition leverages over $50 million invested in GRID AI since 2019, targeting a market expected to see AI infrastructure investments exceeding $2.8 trillion by 2029.
Entero Therapeutics (NASDAQ:ENTO) ha annunciato una acquisizione trasformativa di GRID AI Corp, posizionandosi nel mercato in rapida crescita delle infrastrutture energetiche basate sull'IA. La piattaforma di GRID AI utilizza IA e apprendimento automatico per gestire risorse energetiche distribuite e bilanciare domanda e offerta in tempo reale.
La struttura dell'accordo assegna ai azionisti di GRID AI l'82,5% della proprietà delle azioni ordinarie completamente diluite di ENTO, mentre gli azionisti esistenti di ENTO mantengono un 17,5%. La tecnologia di GRID AI risponde alle crescenti esigenze energetiche dei data center IA, con Goldman Sachs che prevede che la domanda globale di energia per data center aumenterà di circa 50% entro il 2027 e fino a 165% entro il 2030 rispetto ai livelli del 2023.
L'acquisizione sfrutta oltre $50 milioni investiti in GRID AI dal 2019, puntando a un mercato che si prevede vedrà investimenti in infrastrutture IA superiori a $2,8 trilioni entro il 2029.
Entero Therapeutics (NASDAQ:ENTO) ha anunciado una adquisición transformadora de GRID AI Corp, situándose en el mercado de infraestructura energética impulsada por IA en rápido crecimiento. La plataforma de GRID AI utiliza IA y aprendizaje automático para gestionar recursos energéticos distribuidos y equilibrar la oferta y la demanda en tiempo real.
La estructura del acuerdo concede a los accionistas de GRID AI un 82,5% de la propiedad de las acciones comunes totalmente diluidas de ENTO, mientras que los accionistas existentes de ENTO retienen un 17,5%. La tecnología de GRID AI aborda las crecientes demandas de energía de los data centers de IA, con Goldman Sachs proyectando que la demanda global de energía de data centers aumente en aproximadamente un 50% para 2027 y hasta un 165% para 2030 respecto a los niveles de 2023.
La adquisición aprovecha más de $50 millones invertidos en GRID AI desde 2019, apuntando a un mercado que se espera que supere $2,8 billones en inversiones en infraestructura de IA para 2029.
Entero Therapeutics (NASDAQ:ENTO)가 GRID AI Corp를 전략적 인수로 발표하며 AI 에너지 인프라 시장의 빠르게 성장하는 분야에 위치하게 되었습니다. GRID AI의 플랫폼은 AI와 기계 학습을 활용해 분산 에너지 자원을 관리하고 실시간으로 전력 공급과 수요를 균형 있게 맞춥니다.
거래 구조에 따르면 GRID AI 주주들이 ENTO의 완전 희석 보통주 지분의 82.5%를 소유하게 되며, 기존 ENTO 주주들은 17.5%를 보유합니다. GRID AI의 기술은 AI 데이터 센터의 급증하는 전력 수요를 해결하며 골드만 삭스는 2027년까지 데이터 센터의 전력 수요가 전 세계적으로 약 50% 증가하고 2030년까지 2023년 대비 최대 165%까지 증가할 것으로 전망합니다.
이번 인수는 2019년 이후 GRID AI에 투자된 $50백만 이상의 투자를 활용하며, 2029년까지 AI 인프라에 대한 투자가 $2.8조를 초과할 것으로 예상되는 시장을 겨냥합니다.
Entero Therapeutics (NASDAQ:ENTO) a annoncé une acquisition transformative de GRID AI Corp, la positionnant sur le marché en plein essor des infrastructures énergétiques basées sur l'IA. La plateforme de GRID AI utilise l'IA et l'apprentissage automatique pour gérer des ressources énergétiques distribuées et équiibrer l'offre et la demande en temps réel.
La structure de l'accord accorde aux actionnaires de GRID AI 82,5% de la propriété des actions ordinaires entièrement diluées d'ENTO, tandis que les actionnaires existants d'ENTO conservent 17,5%. La technologie de GRID AI répond aux demandes énergétiques croissantes des centres de données IA, Goldman Sachs prévoyant que la demande mondiale d'énergie des data centers augmentera d'environ 50% d'ici 2027 et jusqu'à 165% d'ici 2030 par rapport aux niveaux de 2023.
L'acquisition s'appuie sur plus de $50 millions investis dans GRID AI depuis 2019, visant un marché où les investissements dans les infrastructures IA devraient dépasser $2,8 trillions d'ici 2029.
Entero Therapeutics (NASDAQ:ENTO) hat eine transformativen Zukauf von GRID AI Corp angekündigt und positioniert sich damit im rasch wachsenden Markt für KI-Energie-Infrastruktur. Die GRID AI-Plattform nutzt KI und maschinelles Lernen, um verteilte Energieressourcen zu verwalten und Angebot und Nachfrage in Echtzeit auszugleichen.
Die Struktur des Deals sieht vor, dass GRID AI-Aktionäre 82,5% des Eigentums an ENTOs vollständig verdünnten Stammaktien erhalten, während bestehende ENTO-Aktionäre 17,5% behalten. Die Technologie von GRID AI adressiert den zunehmenden Energiebedarf von KI-Rechenzentren; Goldman Sachs geht davon aus, dass die globale Nachfrage nach Rechenzentrum-Strom bis 2027 um ca. 50% zunimmt und bis 2030 im Vergleich zu 2023 um bis zu 165% steigt.
Die Übernahme baut auf über $50 Millionen investiert in GRID AI seit 2019 auf und zielt auf einen Markt, in dem Investitionen in KI-Infrastruktur voraussichtlich $2,8 Billionen bis 2029 übersteigen werden.
Entero Therapeutics (NASDAQ:ENTO) أعلنت عن استحواذ transformative على GRID AI Corp، مما يجعلها في سوق بنية الطاقة المعتمدة على الذكاء الاصطناعي الذي يشهد نمواً سريعاً. تستخدم منصة GRID AI الذكاء الاصطناعي والتعلم الآلي لإدارة الموارد الطاقة الموزعة وتوازن الإمداد والطلب في الوقت الفعلي.
هيكل الصفقة يمنح المساهمين في GRID AI 82.5% من ملكية أسهم ENTO العادية المخفَّفة بالكامل، بينما يحتفظ المساهمون الحاليون في ENTO بـ 17.5%. تتعامل تكنولوجيا GRID AI مع الطلبات المتزايدة على الطاقة من مراكز بيانات AI، مع توقع Goldman Sachs أن الطلب العالمي على طاقة مراكز البيانات سيزداد بنحو 50% بحلول 2027 وحتى 165% في 2030 مقارنة بمستويات 2023.
تستفيد الصفقة من أكثر من $50 مليون مُستثمر في GRID AI منذ 2019، مستهدفة سوقاً من المتوقع أن تتجاوز فيه استثمارات البنية التحتية لـ AI $2.8 تريليون بحلول 2029.
Entero Therapeutics (NASDAQ:ENTO)宣布对GRID AI Corp的变革性收购,使其在快速增长的以AI为核心的能源基础设施市场中占据位置。GRID AI的平台利用AI和机器学习来管理分布式能源资源,并实现供需的实时平衡。
交易结构规定GRID AI股东持有ENT O的全部稀释普通股82.5%的所有权,而ENT O现有股东保留< b>17.5%。GRID AI的技术应对来自AI数据中心的日益增长的用电需求,高盛预测全球数据中心用电需求到2027年将增加约50%,到2030年相对于2023年将增加高达165%。
此次收购利用自2019年以来在GRID AI投资的超过$5,000万,目标市场预计到2029年AI基础设施投资将超过$2.8万亿美元。
- Strategic entry into AI energy infrastructure market with projected $2.8 trillion investment by 2029
- Scalable SaaS revenue model targeting utilities, retailers, and hyperscalers
- Access to established technology with $50 million prior investment since 2019
- Positioned to capitalize on projected 165% growth in data-center power demand by 2030
- Significant dilution for existing ENTO shareholders, retaining only 17.5% ownership
- Major shift from therapeutic focus requires complete business transformation
- Loss of control with GRID AI shareholders gaining right to appoint 5 of 7 directors
- Requires NASDAQ approval and shareholder vote for change of control
Insights
ENTO's acquisition of GRID AI represents a complete strategic pivot from therapeutics to AI energy infrastructure, significantly diluting existing shareholders.
This acquisition marks a dramatic transformation for Entero Therapeutics (ENTO), shifting from what appears to be a pharmaceutical background (based on the company name) to the AI energy-infrastructure sector. The transaction fundamentally alters ENTO's business model, market positioning, and ownership structure.
The deal structure reveals significant dilution for existing ENTO shareholders, who will retain only
GRID AI brings technology that addresses a legitimate market need – managing the growing power demands of AI data centers while balancing grid reliability. With
The strategic rationale presented aligns with significant market trends, particularly the projected
ENTO enters the booming AI energy management market through GRID AI acquisition, targeting the critical intersection of surging data center power demands and grid reliability.
GRID AI's technology addresses a critical infrastructure challenge in the AI revolution – balancing explosive data center power demand with grid reliability. The company's platform sits at the crucial nexus between utilities struggling with capacity constraints and hyperscalers racing to deploy AI infrastructure.
The core technology consists of two complementary platforms: Dynamic Load Shaping™ (DLS) and an Aggregation Management Platform (AMP). These systems use edge computing and AI to orchestrate millions of distributed energy resources – from EV chargers to batteries and HVAC systems – creating a more flexible, responsive electrical grid. This capability is increasingly valuable as data centers create unprecedented localized power demands that threaten to destabilize electrical infrastructure.
Market timing appears opportune, with Goldman Sachs projecting global data center power consumption to reach 92 gigawatts by 2027 – a
GRID AI's competitive positioning centers on helping utilities defer costly grid upgrades while enabling data centers to operate without disrupting consumer reliability. The platform creates value by transforming distributed energy resources into coordinated, grid-balancing assets through AI-driven optimization – essentially creating virtual power plants from aggregated smaller resources.
While the press release highlights significant investment (
Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler spending on data centers, and rapid growth in behind-the-meter energy storage solutions
BOCA RATON, FL / ACCESS Newswire / October 1, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("ENTO" or the "Company") today announced it has acquired
Over
"This transaction is transformative for ENTO," said Jason Sawyer, Interim Chief Executive Officer of ENTO. "By combining GRID AI's grid-edge intelligence with our public-company platform, we intend to scale solutions that help utilities and hyperscalers meet unprecedented AI-driven power demand while improving grid reliability for consumers and enterprises alike."
Hyperscalers are redefining power demand; AI build-out fuels multi-trillion-dollar capex
AI workloads are driving a step-function increase in electricity consumption from data centers. Goldman Sachs Research projects global data-center power demand to rise ~
Recent marquee commitments underscore the scale: for example, a
Where GRID AI fits: balancing the grid between consumers and corporations
Governments and network operators face an urgent challenge: managing increasingly peaky, localized loads from AI data centers while integrating variable renewables and protecting consumer reliability. GRID AI's DLS™ platform directly addresses this challenge by unlocking flexible demand from millions of devices, enabling automated demand shaping, price-responsive load, and DER aggregation that can defer costly grid upgrades and balance enterprise data-center loads with consumer needs.
Strategic rationale for ENTO
• Entry into a secular growth market: The acquisition positions ENTO squarely within the AI + energy nexus, a sector with strong tailwinds and no signs of slowing, per multiple investment-bank research outlooks on data-center power growth.
• Scalable software & services model: GRID AI's grid-edge platform targets recurring SaaS-like revenues from utilities and retailers, with potential to expand into industrial, commercial and hyperscaler demand-side solutions.
• Public-company springboard: ENTO expects that its public-market access can accelerate GRID AI's go-to-market, partnerships, and project financing alongside utilities and large energy users.
• Portfolio diversification: The acquisition broadens ENTO's strategy into critical infrastructure software, complementing existing capabilities and opening new adjacencies in energy flexibility, virtual power plants (VPPs), and transactive energy.
Transaction details
Under the terms of the agreement, ENTO acquired
To the extent required by NASDAQ's change of control rules and regulations, ENTO will file an initial listing application for its common stock.
About GRID AI
GRID AI is a grid-edge technology business providing Dynamic Load Shaping™, DER aggregation, and AI-driven orchestration to enable a future-proof, transactive grid. Its Aggregation Management Platform leverages IoT, AI/ML and edge analytics to forecast, optimize and dispatch flexible demand across millions of devices for utilities, retailers and large energy users. www.grid-ai.com
About Entero Therapeutics, Inc. (NASDAQ:ENTO)
Entero Therapeutics is a publicly listed company on Nasdaq. Entero Therapeutics is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company's programs address significant unmet needs in GI health and comprise development of Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. Following completion of the GRID AI acquisition, ENTO intends to continue these prior operations and to operate GRID AI as a wholly owned subsidiary and pursue opportunities at the intersection of AI and energy infrastructure.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding strategic benefits of the acquisition, market opportunities, product capabilities, stockholder approval of the transaction, Nasdaq's approval of an initial listing application, if any, and future operating results. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. Important factors include, among others, our business strategy; the risk that regulatory or third-party approvals are delayed or not obtained; integration challenges; market adoption; competitive dynamics; macroeconomic and energy-market conditions; and other risks detailed from time to time in ENTO's SEC filings. ENTO undertakes no obligation to update forward-looking statements.
Investor & Media Contacts:
Entero Investor Relations
investors@enterothera.com
SOURCE: Entero Therapeutics, Inc.
View the original press release on ACCESS Newswire